MS Drug Linked As Possible Cause Of Thrombotic Microangiopathy

In a letter in the March 27th issue of the New England Journal of Medicine, Scottish researchers announced that they’d found evidence linking the MS drug Rebif to the formation of “thrombotic microangiopathy.” This condition causes serious blood clots to form in small blood vessels in different parts of the body. The condition is rare, but it is potentially life threatening.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news